Check out our new Timeline feature to give you the latest updates on all the stocks you follow. Clickhere to set up your Timeline.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksXps Pensions Share News (XPS)

Share Price Information for Xps Pensions (XPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 351.00
Bid: 349.00
Ask: 358.00
Change: 1.00 (0.28%)
Spread: 9.00 (2.579%)
Open: 350.00
High: 356.00
Low: 344.00
Prev. Close: 351.00
XPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors buy following Proximagen deal

Thu, 05th Aug 2010 16:51

Three directors in AIM-quoted biotech sector consolidator Proximagen have added to their holdings following the company's deal with BrainCells Inc for its sabcomeline programme.The Proximagen share price was flat yesterday but the news of the share buying sparked it into life and it ended up 16.5p at 100p. Chief executive Ken Mulvany, finance director James Hunter and non-exec Michael Ashton each bought 15,000 shares at an average price of 84p a share. The shares were bought on 4 and 5 August. Mulvany owns 1.39% of Proximagen, while Hunter owns 20,000 shares and Ashton 41,384 shares. BCI will pay Proximagen an up-front fee and milestone payments worth up to $51m for sabcomeline, as well as royalties on sales. However, most of this cash will not be paid for years and that assumes the clinical trials go as planned. BCI will own the worldwide rights to sabcomeline, which was acquired by Proximagen in February when it paid 6p a share for AIM-quoted Minster Pharmaceuticals, which valued the drug developer at £4.3m. Minster came with £3.5m in cash. Sabcomeline is a treatment for cognitive decline in schizophrenia, which was licensed from GlaxoSmithKline. This is not a core area for Proximagen, which focuses on treatments for neurological conditions. BCI will be responsible for milestone and royalty payments to GSK, as well as the clinical development, regulatory filing and commercialisation of the drug. A phase II trial is planned. In June 2009, Proximagen raised £49m at 140p a share. Proximagen still had £51m in cash and bank deposits at the end of May 2010. There was an outflow from operations of £3.5m in the year to May 2010. Proximagen is valued at £57.4m so there is little upside from its drugs recognised in the share price. Prior to today's share price rise the company was trading at below cash. Minnesota-based Upsher-Smith agreed a similar deal to the BCI one for PRX1, which is a programme for the symptomatic treatment of Parkinson's disease based on an improved version of L-Dopa - a known treatment. The upfront and milestone payments alone could come to $232m (£117m). Again most of these payments are a long way off, although Upsher-Smith did invest $6m at 227p a share in October 2008. Top Director BuyseXpansys (XPS) Director name: Mr Graham DawberAmount purchased: 339,000 @ 7.25p Value: £24,578Proximagen Group (PRX) Director name: Mr James Douglas HunterAmount purchased: 15,000 @ 84.00p Value: £12,600Proximagen Group (PRX) Director name: Mr Kenneth MulvanyAmount purchased: 15,000 @ 84.00p Value: £12,600Proximagen Group (PRX) Director name: Mr Michael AshtonAmount purchased: 15,000 @ 84.00p Value: £12,600MS International (MSI) Director name: Mr David PyleAmount purchased: 10,000 @ 121.50p Value: £12,150Top Director SellsHeavitree.A (HVTA) Director name: Mr Rodney J GlanvilleAmount sold: 7,000 @ 170.00p Value: £11,900
More News
15 Jan 2014 17:55

2ND UPDATE: Peter Jones Swoops For Expansys As He Acquires Majority Stake

LONDON (Alliance News) - Entrepreneur Peter Jones is set to make a takeover offer for Expansys PLC after Wednesday upping his stake in the online smartphone and laptop seller to 50.92%. Under stock market rules, Jones, who is Expansys' non-executive deputy chairman, must make an offer for t

Read more
15 Jan 2014 17:33

UPDATE: Peter Jones Swoops For Expansys As He Acquires Majority Stake

LONDON (Alliance News) - Entrepreneur Peter Jones must make a takeover over for Expansys after Wednesday upping his stake in the online smartphone and laptop seller to 50.92%. Under stock market rules, Jones, who is Expansys' non-executive deputy chairman, must make an offer for the remaini

Read more
15 Jan 2014 16:25

Peter Jones Swoops For Expansys As He Acquires Majority Stake

LONDON (Alliance News) - Entrepreneur Peter Jones must make a takeover over for Expansys after Wednesday upping his stake in the online smartphone and laptop seller to 50.92%. Under takeover rules, Jones must make an offer for the remaining shares of the company. The takeover code say

Read more
14 Oct 2013 11:12

DIRECTOR DEALINGS: Expansys Issues Shares To Director

Read more
21 Mar 2013 17:09

STOCKS NEWS EUROPE-UK small caps close down 0.5 pct

The FTSE Small Caps index close down 0.5 percent, compared to falls of 0.7 percent on the blue-chip FTSE 100 0.4 percent on the FTSE 250 mid-cap index E-commerce and consumer technology company Expansys slumps 35 percent after the company issues a profit warning, stating that trading in the

Read more
21 Mar 2013 12:15

STOCKS NEWS EUROPE-UK small caps off 0.1 pct, outperform blue-chips

The FTSE Small Caps index is down 0.1 percent by around midday, outpeforming bigger declines of 0.8 percent on the blue-chip FTSE 100 and 0.6 percent on the FTSE 250 mid-cap index. E-commerce and consumer technology company Expansys slumps 35.4 percent after the company issues a profit war

Read more
17 Aug 2012 13:37

Small caps round-up: AEA Tech, Expansys, HgCapital ...

Trading since April 1st at AEA Technology Group has remained challenging, as expected, but the energy and sustainability consultancy stressed that good progress is being made in the implementation of the business plan. Discussion over the firm's strategic options to realise its value are on-going wi

Read more
8 Aug 2012 10:15

Small Caps round-up: eXpansys, Oxford Biomedica, Dawson International

eXpansys, the online electronics retailer has delivered a 33 per cent increase in turnover in the 12 months to the end of April. Total revenues for the year were 108.5m pounds, up 24pc on a like-for-like basis. Profits before tax were 4.3m pounds, a rise of 27pc on the prior year. The market had cle

Read more
17 Apr 2012 11:18

Small caps round-up: Expansys, Scancell, Inspired Energy...

Expansys, the eCommerce company, has struck lucky in Istanbul. Its subsidiary PJ Media has won a contract to supply the official online store for Vodafone Turkey. By 11:06 eXpansys had gained 8.6%. Scancell Holdings, the developer of therapeutic cancer vaccines, has announced it has recruited enoug

Read more
1 Mar 2012 10:30

Small caps round-up: K3, Densitron, Innovation...

Software firm K3 Business Technology Group has received a number of indicative proposals at levels materially higher than the current share price, which it will explore these under a formal sale process and is now consequently in an offer period. Shares in the firm leapt 21.75 percent to 187.50p.

Read more
28 Feb 2012 16:00

Asian Citrus non-exec squeezes the funds to buy shares

A non-Executive Director of Asian Citrus, an AIM-100 Chinese orange grower, has bought 256,000 shares for himself and his wife. Peregrine Moncreiffe and his wife, Miranda Moncreiffe, purchased the shares at an average price of 37.95p each for a total of £97,152. Winterthur Pension Management, in

Read more
10 Jan 2012 10:50

Expansys sees 30% sales growth

Expansys, the online electronics retailer, has climbed 6% this morning on news its November and December sales are 30% ahead of the equivalent period of 2010. The growth has come from the firm's own brand websites and particularly in the Asia and US divisions. Expansys's Chief Executive, Anthony C

Read more
14 Dec 2011 07:19

eXpansys posts half year profit

Online wireless and consumer technology retailer eXpansys reported a half year profit compared to a loss during the same six months a year earlier after strong growth particularly in the US and Asia. The group, which sells smartphones, laptops and cables, said pre-tax profit came in at £0.8m for th

Read more
15 Aug 2011 13:17

Dragon's Den's Peter Jones puts up the money

Dragon's Den entrepreneur and business tycoon Peter Jones has used some of the proceeds of his sale of one of his telecoms businesses, Wireless Logic, to buy more shares in the online consumer electronics business eXpansys He bought 35,634,200 shares at 2.42p. Jones, the non-executive deputy cha

Read more
27 Jul 2011 15:45

EXPANSYS bosses buy into rally

Directors at EXPANSYS have been clubbing together to buy big stakes in the ailing online smartphone retailer, taking advantage of a continuing rally. Bob Wigley took the biggest stake, taking about 6.6m shares at 1.49p a time and lifting his stake to 8.4m shares, about 0.73% of the company. Brian C

Read more

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.